Skip to main
ITRM
ITRM logo

ITRM P/E Ratio

P/E Ratio as of Jun 16, 2025: -1.00

Average-0.9790
Median-0.9800
Minimum-1.04
Maximum-0.9200
-1.00
Past Month-0.07 (7.53%)
The P/E ratio for ITRM is -1.00 as of Jun 16, 2025. This represents a increase of 28.21% compared to its 12-month average P/E ratio of -0.78. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Iterum Therapeutics Plc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Iterum Therapeutics Plc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Iterum Therapeutics Plc to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ITRM P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$0.9699-0.97
May 1, 2025$1.08-0.82
Apr 1, 2025$1.17-0.89
Mar 3, 2025$1.33-1.01
Feb 3, 2025$1.54-0.77
Jan 2, 2025$1.83-0.91

ITRM End of Year P/E Ratio

DateP/E ratioChange
2025-1.00+13.64%
2024-0.88+8.64%
2023-0.81+237.50%
2022-0.24-52.94%
2021-0.51+37.84%
2020-0.37

FAQs About Iterum Therapeutics Plc (ITRM) P/E ratio

The latest P/E ratio of ITRM is -1.00, as of Jun 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Iterum Therapeutics Plc’s last 12-month average P/E ratio is -0.78, compared to its current P/E ratio of -1.00. This reflects a increase of 28.21%.

Iterum Therapeutics Plc’s current P/E ratio of -1.00 is higher than its last 12-month average P/E of -0.78. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Iterum Therapeutics Plc’s average P/E ratio over the last 3 years is -0.8. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Iterum Therapeutics Plc’s average P/E ratio over the last 5 years is 0.01. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Iterum Therapeutics Plc (ITRM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.